NO301709B1 - Fremgangsmåte for fremstilling av formoterol og beslektede forbindelser - Google Patents

Fremgangsmåte for fremstilling av formoterol og beslektede forbindelser

Info

Publication number
NO301709B1
NO301709B1 NO931058A NO931058A NO301709B1 NO 301709 B1 NO301709 B1 NO 301709B1 NO 931058 A NO931058 A NO 931058A NO 931058 A NO931058 A NO 931058A NO 301709 B1 NO301709 B1 NO 301709B1
Authority
NO
Norway
Prior art keywords
formoterol
related compounds
preparation
directed
present
Prior art date
Application number
NO931058A
Other languages
English (en)
Norwegian (no)
Other versions
NO931058L (no
NO931058D0 (no
Inventor
Jan William Trofast
Edib Jakupovic
Lena Katarina Mansson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO931058L publication Critical patent/NO931058L/no
Publication of NO931058D0 publication Critical patent/NO931058D0/no
Publication of NO301709B1 publication Critical patent/NO301709B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
NO931058A 1990-09-26 1993-03-23 Fremgangsmåte for fremstilling av formoterol og beslektede forbindelser NO301709B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process
PCT/SE1991/000643 WO1992005147A1 (en) 1990-09-26 1991-09-25 New process for preparing formoterol and related compounds

Publications (3)

Publication Number Publication Date
NO931058L NO931058L (no) 1993-03-23
NO931058D0 NO931058D0 (no) 1993-03-23
NO301709B1 true NO301709B1 (no) 1997-12-01

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931058A NO301709B1 (no) 1990-09-26 1993-03-23 Fremgangsmåte for fremstilling av formoterol og beslektede forbindelser

Country Status (28)

Country Link
EP (1) EP0550612B1 (ru)
JP (1) JP2801401B2 (ru)
KR (1) KR0179639B1 (ru)
AT (1) ATE134990T1 (ru)
AU (1) AU652386B2 (ru)
BG (1) BG61605B1 (ru)
CA (1) CA2091343C (ru)
CZ (1) CZ284256B6 (ru)
DE (1) DE69117768T2 (ru)
DK (1) DK0550612T3 (ru)
EE (1) EE02979B1 (ru)
ES (1) ES2084831T3 (ru)
FI (1) FI111714B (ru)
GR (1) GR3020134T3 (ru)
HK (1) HK52297A (ru)
HU (1) HU214054B (ru)
IE (1) IE74387B1 (ru)
IS (1) IS1684B (ru)
LT (1) LT3813B (ru)
LV (1) LV10770B (ru)
NO (1) NO301709B1 (ru)
PL (1) PL166434B1 (ru)
PT (1) PT99051B (ru)
RU (1) RU2079486C1 (ru)
SE (1) SE9003057D0 (ru)
SG (1) SG43150A1 (ru)
SK (1) SK22793A3 (ru)
WO (1) WO1992005147A1 (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
ES2178015T3 (es) * 1996-11-11 2002-12-16 Sepracor Inc Procedimiento de preparacion de isomeros de formoterol opticamente puros.
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
WO2002066021A2 (de) * 2001-02-22 2002-08-29 Universitätsklinikum Charite Medizinische Fakultät Der Humboldt-Universität Zu Berlin Inhibitoren der protein kinase d und der protein kinase 2 als mittel zur hemmung von tumorzellen und zur stimulierung der angiogehese
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
AU2008320590A1 (en) * 2007-10-29 2009-05-07 Generics [Uk] Limited Novel chromatography methods
BRPI0822693A2 (pt) 2008-05-13 2015-07-07 Astrazeneca Ab Derivados de quinuclidina como antagonistas do receptor muscarínico m3
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250A (zh) * 2022-09-02 2022-11-22 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2305092A1 (de) 1972-02-05 1973-08-16 Yamanouchi Pharma Co Ltd Alpha-aminomethylbenzylalkoholderivate
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
JPS643121A (en) 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
FI931333A0 (fi) 1993-03-25
EE02979B1 (et) 1997-04-15
WO1992005147A1 (en) 1992-04-02
EP0550612A1 (en) 1993-07-14
CZ44293A3 (en) 1994-01-19
PT99051A (pt) 1992-08-31
IE74387B1 (en) 1997-07-30
NO931058L (no) 1993-03-23
IS3756A7 (is) 1992-03-27
LT3813B (en) 1996-03-25
CZ284256B6 (cs) 1998-10-14
CA2091343A1 (en) 1992-03-27
GR3020134T3 (en) 1996-08-31
SK22793A3 (en) 1993-07-07
CA2091343C (en) 2002-07-09
SE9003057D0 (sv) 1990-09-26
PT99051B (pt) 1999-02-26
FI111714B (fi) 2003-09-15
RU2079486C1 (ru) 1997-05-20
DE69117768T2 (de) 1996-08-29
EP0550612B1 (en) 1996-03-06
LTIP1715A (en) 1995-07-25
HK52297A (en) 1997-05-02
FI931333A (fi) 1993-04-22
KR0179639B1 (ko) 1999-05-15
HU214054B (en) 1997-12-29
AU8652091A (en) 1992-04-15
ES2084831T3 (es) 1996-05-16
JP2801401B2 (ja) 1998-09-21
IS1684B (is) 1998-02-24
JPH06501262A (ja) 1994-02-10
NO931058D0 (no) 1993-03-23
HUT65912A (en) 1994-07-28
AU652386B2 (en) 1994-08-25
DK0550612T3 (da) 1996-07-22
SG43150A1 (en) 1997-10-17
LV10770B (en) 1996-04-20
HU9300867D0 (en) 1993-06-28
BG61605B1 (bg) 1998-01-30
PL166434B1 (pl) 1995-05-31
IE913373A1 (en) 1992-04-08
LV10770A (lv) 1995-08-20
BG97576A (bg) 1994-03-31
ATE134990T1 (de) 1996-03-15
DE69117768D1 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
NO301709B1 (no) Fremgangsmåte for fremstilling av formoterol og beslektede forbindelser
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
LU91555I2 (fr) "Brinzolamide et timolol optionnellement sous de sels pharmaceutiquement acceptables te que la combination du produit brinzolamide/timolol maléate (AZARGA)"
RU93005269A (ru) Способ получения формотерола и родственных соединений
SE9404080L (sv) Förfarande för framställning av en optiskt ren enantiomer av formoterol
FI101224B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkoksipyrimidiinijohdannaisten valmistamiseksi
FI98455B (fi) Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
ES2071303T3 (es) Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.
DK0526529T3 (da) "Forbedret fremgangsmåde til fremstilling af substituerede indolonderivater"
FI801769A (fi) Paromomycin-derivat foerfarande foer deras framstaellning och terapeutiska kompositioner daer de ingaor
NO914053L (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO179205C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-piperidinylalkanoylarylsulfonamidderivater
DE3474145D1 (en) Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
NO914452L (no) Fremgangsmaate for fremstilling av isokinolinderivater
RU92016353A (ru) Производные катехола, способ их получения, применение и фармацевтическая композиция
NO173504C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-triazolo-diazepin-derivater

Legal Events

Date Code Title Description
MK1K Patent expired